Reducing the rate and duration of Re- ADMISsions among patients with unipolar disorder and bipolar disorder using smartphone-based monitoring and treatment - the RADMIS trials: Study protocol for two randomized controlled trials

Trials

Volumn 18, Issue 1, 2017, Pages

  Faurholt Jepsen, Maria ^a   Frost, Mads ^b   Martiny, Klaus ^a   Tuxen, Nanna ^a   Rosenberg, Nicole ^a   Busk, Jonas ^c   Winther, Ole ^c   Bardram, Jakob Eyvind ^c   Kessing, Lars Vedel ^a  

^a Rigshospitalet   (Denmark)

^b IT UNIVERSITY OF COPENHAGEN   (Denmark)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIPOLAR DISORDER; CLINICAL OUTCOME; CLINICAL PROTOCOL; COGNITIVE BEHAVIORAL THERAPY; CONTROLLED STUDY; DENMARK; DISEASE SEVERITY; DOCTOR PATIENT RELATION; EMPOWERMENT; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; MAJOR DEPRESSION; MANIA; MENTAL HOSPITAL; MENTAL STRESS; PARALLEL DESIGN; PATIENT ATTITUDE; PATIENT CARE; PATIENT COMPLIANCE; PATIENT MONITORING; PATIENT SATISFACTION; PSYCHOLOGICAL WELL-BEING; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SELF CONCEPT; SINGLE BLIND PROCEDURE; SMARTPHONE; SOCIAL PSYCHOLOGY; SYMPTOM; TREATMENT DURATION; COGNITIVE THERAPY; DEVICES; LENGTH OF STAY; MENTAL HEALTH; METHODOLOGY; MOBILE APPLICATION; PROCEDURES; PSYCHOLOGICAL FEEDBACK; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; SELF REPORT; TELEMEDICINE; TIME FACTOR; TREATMENT OUTCOME;

BIPOLAR DISORDER; COGNITIVE THERAPY; DENMARK; FEEDBACK, PSYCHOLOGICAL; HUMANS; LENGTH OF STAY; MENTAL HEALTH; MOBILE APPLICATIONS; PATIENT READMISSION; PHYSICIAN-PATIENT RELATIONS; PSYCHIATRIC STATUS RATING SCALES; RESEARCH DESIGN; SELF REPORT; SINGLE-BLIND METHOD; SMARTPHONE; TELEMEDICINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 85027576654     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-017-2015-3     Document Type: Article

References (68)

1. Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RMA, Petukhova M. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2007; 64(5): 543-52. 10.1001/archpsyc.64.5.5431931566
2. Kessler RC, Berglund P, Demler O. The epidemiology of major depressive disorder: results from the national comorbidity survey replication (ncs-r). JAMA 2003; 289(23): 3095-105. 10.1001/jama.289.23.3095
3. Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 2013; 382(9904): 1575-86. 10.1016/S0140-6736(13)61611-6
4. Olesen J, Gustavsson A, Svensson M, Wittchen H-U, Jönsson B. on behalf of the CDBE2010 study group, et al. The economic cost of brain disorders in Europe. Eur J Neurol 2012; 19(1): 155-62. 10.1111/j.1468-1331.2011.03590.x
5. Arbejdsgruppe under Regeringens udvalg om Psykiatri. Indsatsen for mennesker med psykiske lidelser-kapacitet, sammenhæng og strktur. Bilagsrapport 1. Afrapportering fra Arbejdsgruppemøde under Regeringens udvalg om Psykiatri. 2013
6. The Psychiatric Central Register. [Internet]. 2016. Available from: http://www.kea.au.dk/da/forskning/det-psykiatriske-centralregister.html_2016. Accessed 11 June 2017
7. Mortensen PB, Agerbo E, Erikson T, Qin P, Westergaard-Nielsen N. Psychiatric illness and risk factors for suicide in Denmark. Lancet Lond Engl 2000; 355(9197): 9-12. 10.1016/S0140-6736(99)06376-X
8. Kessing LV, Hansen MG, Andersen PK. Course of illness in depressive and bipolar disorders. Naturalistic study, 1994-1999. Br J Psychiatry 2004; 185: 372-7. 10.1192/bjp.185.5.372
9. Kessing LV, Hansen HV, Hvenegaard A, Christensen EM, Dam H, Gluud C. Treatment in a specialised out-patient mood disorder clinic v. standard out-patient treatment in the early course of bipolar disorder: randomised clinical trial. Br J Psychiatry 2013; 202(3): 212-9. 10.1192/bjp.bp.112.113548
10. Nørregaard L, Løventoft P, Frøkjær E, Lauritsen L, Olsson E, Andersen L, et al. Patient expectations and experiences from a clinical study in psychiatric care using a self-monitoring system. In: NordiCHI'14: Proceedings of the 8th Nordic Conference on Human-Computer Interaction: Fun, Fast, Foundational. Helsinki: Association for Computing Machinery; 2014. p. 991-4
11. Faurholt-Jepsen M, Frost M, Vinberg M, Christensen EM, Bardram JE, Kessing LV. Smartphone data as objective measures of bipolar disorder symptoms. Psychiatry Res 2014; 217(1-2): 124-7. 10.1016/j.psychres.2014.03.009
12. Faurholt-Jepsen M, Vinberg M, Frost M, Christensen EM, Bardram JE, Kessing LV. Smartphone data as an electronic biomarker of illness activity in bipolar disorder. Bipolar Disord. 2015;17(7):715-28. doi:10.1111/bdi.12332
13. Faurholt-Jepsen M. Behavioral activities collected through smartphones and the association with illness activity in bipolar disorder. Int J Methods Psychiatr Res. 2016. In press
14. Bardram J, Frost M, Szanto K, Margu G. The MONARCA self-assessment system: a persuasive personal monitoring system for bipolar patients. In: Proceedings of the 2nd ACM SIGHIT International Health Informatics Symposium (IHI'12) ACM, New York, NY, USA, 21-30. ACM New York, NY, USA; 2012. p. 21-30
15. Faurholt-Jepsen M, Vinberg M, Christensen EM, Frost M, Bardram J, Kessing LV. Daily electronic self-monitoring of subjective and objective symptoms in bipolar disorder-the MONARCA trial protocol (MONitoring, treAtment and pRediCtion of bipolAr disorder episodes): a randomised controlled single-blind trial. BMJ Open. 2013;3(7). doi:10.1136/bmjopen-2013-003353
16. Watts SE, Turnell A, Kladnitski N, Newby JM, Andrews G. Treatment-as-usual (TAU) is anything but usual: a meta-analysis of CBT versus TAU for anxiety and depression. J Affect Disord. 2015; 175: 152-67. 10.1016/j.jad.2014.12.025
17. Scott J, Paykel E, Morriss R, Bentall R, Kinderman P, Johnson T. Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. Br J Psychiatry J Ment Sci. 2006; 188: 313-20. 10.1192/bjp.188.4.313
18. Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002; 59(6): 530-7. 10.1001/archpsyc.59.6.530
19. Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Licht RW. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry 2013; 170(11): 1249-62. 10.1176/appi.ajp.2013.130201854091043
20. Lam DH, Watkins ER, Hayward P, Bright J, Wright K, Kerr N. A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year. Arch Gen Psychiatry 2003; 60(2): 145-52. 10.1001/archpsyc.60.2.145
21. Lam DH, Hayward P, Watkins ER, Wright K, Sham P. Relapse prevention in patients with bipolar disorder: cognitive therapy outcome after 2years. Am J Psychiatry 2005; 162(2): 324-9. 10.1176/appi.ajp.162.2.324
22. Miklowitz DJ, Otto MW, Frank E, Reilly-Harrington NA, Kogan JN, Sachs GS. Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial. Am J Psychiatry 2007; 164(9): 1340-7. 10.1176/appi.ajp.2007.070203113579578
23. Perry A, Tarrier N, Morriss R, McCarthy E, Limb K. Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment. BMJ 1999; 318(7177): 149-53. 10.1136/bmj.318.7177.14927688
24. Simon GE, Ludman EJ, Bauer MS, Unützer J, Operskalski B. Long-term effectiveness and cost of a systematic care program for bipolar disorder. Arch Gen Psychiatry 2006; 63(5): 500-8. 10.1001/archpsyc.63.5.500
25. Scott J, Colom F. Gaps and limitations of psychological interventions for bipolar disorders. Psychother Psychosom. 2008;77(1):4-11
26. Watkins ER. Depressive rumination: investigating mechanisms to improve cognitive behavioural treatments. Cogn Behav Ther 2009; 38(S1): 8-14. 10.1080/165060709029806953357968
27. Ebert DD, Zarski A-C, Christensen H, Stikkelbroek Y, Cuijpers P, Berking M, et al. Internet and computer-based cognitive behavioral therapy for anxiety and depression in youth: a meta-analysis of randomized controlled outcome trials. PLoS ONE [Internet]. 2015;10(3). Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364968/. Accessed on 4 Feb 2016
28. Ly KH, Janni E, Wrede R, Sedem M, Donker T, Carlbring P. Experiences of a guided smartphone-based behavioral activation therapy for depression: a qualitative study. Internet Interv 2015; 2(1): 60-8. 10.1016/j.invent.2014.12.002
29. Morriss RK, Faizal MA, Jones AP, Williamson PR, Bolton C, McCarthy JP. Interventions for helping people recognise early signs of recurrence in bipolar disorder. Cochrane Database Syst Rev. 2007; 1: CD004854
30. Burns MN, Begale M, Duffecy J, Gergle D, Karr CJ, Giangrande E. Harnessing context sensing to develop a mobile intervention for depression. J Med Internet Res 2011; 13(3): e55. 10.2196/jmir.18383222181
31. Doryab A. Detection of behavior change in people with depression. In: Workshops at the Twenty Eighth AAAI Conference. 2014
32. Bardram JE, Frost M, Szánto K, Faurholt-Jepsen M, Vinberg M, Kessing LV. Designing mobile health technology for bipolar disorder: a field trial of the Monarca system. In: Proceedings of the SIGCHI Conference on Human Factors in Computing Systems. CHI: New York; 2013. p. 2627-36
33. Faurholt-Jepsen M, Frost M, Ritz C, Christensen EM, Jacoby AS, Mikkelsen RL. Daily electronic self-monitoring in bipolar disorder using smartphones-the MONARCA I trial: a randomized, placebo-controlled, single-blind, parallel group trial. Psychol Med. 2015; 29: 1-14
34. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978; 133: 429-35. 10.1192/bjp.133.5.429
35. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010; 340: c869. 10.1136/bmj.c8692844943
36. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 2008; 148(4): 295-309. 10.7326/0003-4819-148-4-200802190-00008
37. Chan A-W, Tetzlaff JM, Altman DG, Dickersin K, Moher D. SPIRIT 2013: new guidance for content of clinical trial protocols. Lancet 2013; 381(9861): 91-2. 10.1016/S0140-6736(12)62160-6
38. Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R. SCAN. Schedules for clinical assessment in neuropsychiatry. Arch Gen Psychiatry 1990; 47(6): 589-93. 10.1001/archpsyc.1990.01810180089012
39. Malig C, The civil registration system in Denmark 1996Rockville pike, BethesdaPrinceton University Library: International Institute for Vital Registration and Statistics
40. Munk-Jørgensen P, Mortensen PB. The Danish Psychiatric Central Register. Dan Med Bull 1997; 44(1): 82-4
41. Martell CR, Dimidjian S, Herman-Dunn R, Behavioral activation for depression: a clinician's guide 2010New YorkThe Guilford Press
42. Lejuez CW, Hopko DR, Hopko SD. A brief behavioral activation treatment for depression. Treatment manual. Behav Modif 2001; 25(2): 255-86. 10.1177/0145445501252005
43. Dimidjian S, Hollon SD, Dobson KS, Schmaling KB, Kohlenberg RJ, Addis ME. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol 2006; 74(4): 658-70. 10.1037/0022-006X.74.4.658
44. Cuijpers P, Straten A, Warmerdam L. Behavioral activation treatments of depression: a meta-analysis. Clin Psychol Rev 2007; 27(3): 318-26. 10.1016/j.cpr.2006.11.001
45. Dobson KS, Hollon SD, Dimidjian S, Schmaling KB, Kohlenberg RJ, Gallop R. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of relapse and recurrence in major depression. J Consult Clin Psychol 2008; 76(3): 468-77. 10.1037/0022-006X.76.3.4682648513
46. Dimidjian S, BarreraJr M, Martell C, Muñoz RF, Lewinsohn PM. The origins and current status of behavioral activation treatments for depression. Annu Rev Clin Psychol 2011; 7(1): 1-38. 10.1146/annurev-clinpsy-032210-104535
47. Ly KH, Trüschel A, Jarl L, Magnusson S, Windahl T, Johansson R, et al. Behavioural activation versus mindfulness-based guided self-help treatment administered through a smartphone application: a randomised controlled trial. BMJ Open [Internet]. 2014;4(1). Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902198/. Accessed 13 June 2016
48. Ly KH, Topooco N, Cederlund H, Wallin A, Bergström J, Molander O, et al. Smartphone-supported versus full behavioural activation for depression: a randomised controlled trial. PLoS ONE [Internet]. 2015;10(5). Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444307/. Accessed 13 June 2016
49. Shen GH, Alloy LB, Abramson LY, Sylvia LG. Social rhythm regularity and the onset of affective episodes in bipolar spectrum individuals. Bipolar Disord 2008; 10(4): 520-9. 10.1111/j.1399-5618.2008.00583.x4090015
50. DeRubeis RJ, Siegle GJ, Hollon SD. Cognitive therapy vs. medications for depression: treatment outcomes and neural mechanisms. Nat Rev Neurosci 2008; 9(10): 788-96. 10.1038/nrn23452748674
51. Watts S, Mackenzie A, Thomas C, Griskaitis A, Mewton L, Williams A. CBT for depression: a pilot RCT comparing mobile phone vs. computer. BMC Psychiatry 2013; 13: 49. 10.1186/1471-244X-13-493571935
52. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6(4): 278-96. 10.1111/j.2044-8260.1967.tb00530.x
53. Rosa AR, Sánchez-Moreno J, Martínez-Aran A, Salamero M, Torrent C, Reinares M. Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health CP EMH. 2007; 3: 5. 10.1186/1745-0179-3-5
54. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983; 24(4): 385-96. 10.2307/2136404
55. WHO. Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med 1998; 28(3): 551-8. 10.1017/S0033291798006667
56. Bech P, Olsen LR. Discovering depression. Ugeskr Laeger 2001; 163(14): 1980-2
57. Bech P, Rasmussen NA, Olsen LR, Noerholm V, Abildgaard W. The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity. J Affect Disord 2001; 66(2-3): 159-64. 10.1016/S0165-0327(00)00309-8
58. Olsen LR, Jensen DV, Noerholm V, Martiny K, Bech P. The internal and external validity of the Major Depression Inventory in measuring severity of depressive states. Psychol Med 2003; 33(2): 351-6. 10.1017/S0033291702006724
59. Bech P, Gefke M, Lunde M, Lauritzen L, Martiny K. The pharmacopsychometric triangle to illustrate the effectiveness of T-PEMF concomitant with antidepressants in treatment resistant patients: a double-blind, randomised, sham-controlled trial revisited with focus on the patient-reported outcomes. Depress Res Treat [Internet]. 2011;2011. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123910/. Accessed 22 Mar 2016
60. Corrigan PW, Salzer M, Ralph RO, Sangster Y, Keck L. Examining the factor structure of the Recovery Assessment Scale. Schizophr Bull 2004; 30(4): 1035-41. 10.1093/oxfordjournals.schbul.a007118
61. Rogers ES, Chamberlin J, Ellison ML, Crean T. A consumer-constructed scale to measure empowerment among users of mental health services. Psychiatr Serv Wash DC 1997; 48(8): 1042-7. 10.1176/ps.48.8.1042
62. Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res 2000; 42(3): 241-7. 10.1016/S0920-9964(99)00130-9
63. Bech P, Olsen LR, Kjoller M, Rasmussen NK. Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 Mental Health subscale and the WHO-Five Well-being Scale. Int J Methods Psychiatr Res 2003; 12(2): 85-91. 10.1002/mpr.145
64. Meyer TJ, Miller ML, Metzger RL, Borkovec TD. Development and validation of the Penn State Worry Questionnaire. Behav Res Ther 1990; 28(6): 487-95. 10.1016/0005-7967(90)90135-6
65. Kessing LV, Hansen HV, Ruggeri M, Bech P. Satisfaction with treatment among patients with depressive and bipolar disorders. Soc Psychiatry Psychiatr Epidemiol 2006; 41(2): 148-55. 10.1007/s00127-005-0012-4
66. Hansen HV, Christensen EM, Dam H, Gluud C, Wetterslev J, Kessing LV. The effects of centralised and specialised intervention in the early course of severe unipolar depressive disorder: a randomised clinical trial. PloS One. 2012;7(3):e32950. doi:10.1371/journal.pone.0032950
67. Schulz KF, Grimes DA. Allocation concealment in randomised trials: defending against deciphering. Lancet 2002; 359(9306): 614-8. 10.1016/S0140-6736(02)07750-4
68. Schulz KF, Grimes DA. Unequal group sizes in randomised trials: guarding against guessing. Lancet 2002; 359(9310): 966-70. 10.1016/S0140-6736(02)08029-7